CM Hospitalar S/A (BVMF:VVEO3)
Brazil flag Brazil · Delayed Price · Currency is BRL
0.6800
-0.0100 (-1.45%)
Last updated: Aug 26, 2026, 4:17 PM GMT-3

CM Hospitalar S/A Cash Flow Statement

Millions BRL. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
56.8718.24-1,415359.92259.73395.16
Depreciation & Amortization
218.38187.01266.85260.61176.3698.19
Other Amortization
132.3143.3644.27---
Loss (Gain) From Sale of Assets
-1.96---16.676.352.28
Asset Writedown & Restructuring Costs
8.668.66222.667.15--
Loss (Gain) From Sale of Investments
1.365.1797.26---
Loss (Gain) on Equity Investments
0.65111.861.683.533
Stock-Based Compensation
-7.633.174.426.944.51-
Provision & Write-off of Bad Debts
27.5626.78109.94-8.465.971.34
Other Operating Activities
-185.34-185.49888.2-208.3493.62-42
Change in Accounts Receivable
149.4156.75216.76-404.93-387.02-67.75
Change in Inventory
-118.2745.16-138.82-684.34-53.06-162.7
Change in Accounts Payable
134.9142.09-397.78-55.49441.66185.57
Change in Income Taxes
-125.25-89.41109-193.82-14.27-132.54
Change in Other Net Operating Assets
-22.5614.0815.0240.11-4.6339.58
Operating Cash Flow
269.1276.5834.15-895.63532.75320.12
Operating Cash Flow Growth
-709.90%--66.42%72.47%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-43.44-45.49-81.62-168.1-152.24-77.95
Sale (Purchase) of Intangibles
-108.06-105.82-103.67-134.18-107.08-48.24
Investment in Securities
-40.37487.37-57.7370.82-1,318-1,184
Other Investing Activities
---29.8-68.15-32.31-105.58
Investing Cash Flow
-191.86336.05-272.790.39-1,609-1,416

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-63.871,450232.351,3891,589
Long-Term Debt Repaid
--506.18-983.02-384.54-296.55-685.85
Net Debt Issued (Repaid)
-372.57-442.31467.4-152.181,092903.26
Issuance of Common Stock
---778.35-652.87
Repurchase of Common Stock
---18.72--40.45-25.36
Common Dividends Paid
---43.48-74.74-112.99-
Other Financing Activities
-106.48-140.34-95.59-226.05-184.3-7.66
Financing Cash Flow
-479.05-582.65309.61325.38754.341,523

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-401.8129.9870.96-569.86-322.29427.51

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
225.66231.09-47.47-1,064380.51242.16
Free Cash Flow Growth
----57.13%77.73%
Free Cash Flow Margin
1.93%2.00%-0.41%-9.60%4.35%3.89%
Free Cash Flow Per Share
0.710.73-0.15-3.541.340.93
Levered Free Cash Flow
134.93323.54-79.81-1,69468.8535.39
Unlevered Free Cash Flow
543.32692.85226.09-1,28168.85277.11

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
273.14512.64412.76450.52245.0178.88
Cash Income Tax Paid
14.5831.3323.9773.5158.4828.66
Change in Working Capital
18.2468.67-195.82-1,298-17.31-137.84